122 related articles for article (PubMed ID: 17199160)
41. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
42. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
43. Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy.
Yilmaz T; Cordero-Coma M; Lavaque AJ; Gallagher MJ; Padula WV
Curr Pharm Biotechnol; 2011 Mar; 12(3):337-46. PubMed ID: 20939800
[TBL] [Abstract][Full Text] [Related]
44. Sub-tenon's corticosteroids for the treatment of macular edema in bone marrow transplant retinopathy.
Walton RC; Vick VL; Greenwald MA
Retina; 1999; 19(2):171-3. PubMed ID: 10213248
[No Abstract] [Full Text] [Related]
45. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
Korodi T; Lachmann B; Kopelent-Frank H
Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253
[TBL] [Abstract][Full Text] [Related]
46. Development of biodegradable controlled release scleral systems of triamcinolone acetonide.
Blatsios G; Tzimas AS; Mattheolabakis G; Panagi Z; Avgoustakis K; Gartaganis SP
Curr Eye Res; 2010 Oct; 35(10):916-24. PubMed ID: 20858113
[TBL] [Abstract][Full Text] [Related]
47. Intraocular sustained-release delivery systems for triamcinolone acetonide.
Mansoor S; Kuppermann BD; Kenney MC
Pharm Res; 2009 Apr; 26(4):770-84. PubMed ID: 19184374
[TBL] [Abstract][Full Text] [Related]
48. [Use of intracameral triamcinolone in pediatric cataract surgery. Diagnostic and therapeutic usefulness].
Abreu JA; Pinto C; Lozano V; Aguilar JJ
Arch Soc Esp Oftalmol; 2015 May; 90(5):248-9. PubMed ID: 25443464
[No Abstract] [Full Text] [Related]
49. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Yolcu Ü; Ilhan A
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):1. PubMed ID: 25635966
[No Abstract] [Full Text] [Related]
50. Endophthalmitis after intravitreal injection of triamcinolone acetonide.
Jonas JB; Kreissig I; Degenring RF
Arch Ophthalmol; 2003 Nov; 121(11):1663-4. PubMed ID: 14609940
[No Abstract] [Full Text] [Related]
51. Sustained-release steroids for the treatment of diabetic macular edema.
Daruich A; Matet A; Behar-Cohen F
Curr Diab Rep; 2015 Nov; 15(11):99. PubMed ID: 26395924
[TBL] [Abstract][Full Text] [Related]
52. Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony.
Jonas JB; Hayler JK; Panda-Jonas S
Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(6):464-5. PubMed ID: 11561798
[No Abstract] [Full Text] [Related]
53. Evolving Role of Regional Depot Corticosteroids in Management of Diabetic Macular Edema.
Kim SJ; Scott IU
Retina; 2017 Dec; 37(12):2201-2207. PubMed ID: 28837536
[No Abstract] [Full Text] [Related]
54. Intravitreal steroids and Eales' disease.
Shahid M; Feroze AH; Ishaq M; Baig MA; Feroze SH
J Pak Med Assoc; 2007 Apr; 57(4):208-9. PubMed ID: 17489532
[TBL] [Abstract][Full Text] [Related]
55. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
Li W; He B; Dai W; Zhang Q; Liu Y
Int Ophthalmol; 2014 Jun; 34(3):465-76. PubMed ID: 23868505
[TBL] [Abstract][Full Text] [Related]
56. Intravitreal triamcinolone and endophthalmitis.
Parke DW
Am J Ophthalmol; 2003 Nov; 136(5):918-9. PubMed ID: 14597047
[No Abstract] [Full Text] [Related]
57. Concentration of intravitreally injected triamcinolone acetonide in aqueous humour.
Jonas JB
Br J Ophthalmol; 2002 Sep; 86(9):1066. PubMed ID: 12185144
[No Abstract] [Full Text] [Related]
58. Echographic localisation of corticosteroid after retrobulbar injection.
Tolentino MJ; Prenner JL; Gendron EK; Maguire AM
Br J Ophthalmol; 2001 May; 85(5):626-7. PubMed ID: 11351972
[No Abstract] [Full Text] [Related]
59. Intravitreal triamcinolone acetonide as adjunctive treatment for neovascular glaucoma.
Bonanomi MT; Susanna R
Clinics (Sao Paulo); 2005 Aug; 60(4):347-50. PubMed ID: 16138243
[No Abstract] [Full Text] [Related]
60. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies.
Araújo J; Garcia ML; Mallandrich M; Souto EB; Calpena AC
Nanomedicine; 2012 Aug; 8(6):1034-41. PubMed ID: 22115598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
